ArticlePeerJ2026
Nomogram model for predicting multivessel disease in coronary artery disease using cardiac function parameters and clinical features.
Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Multivessel disease (MVD) represents a severe phenotype of coronary artery disease and is associated with poor prognosis. Early, non-invasive identification of MVD remains a clinical challenge. This study aimed to develop and validate a nomogram integrating cardiac function parameters and clinical characteristics for individualized prediction of MVD risk. Methods: Clinical data were retrospectively collected from 353 patients with angiographically confirmed coronary artery disease at Guangzhou Red Cross Hospital between January 2023 and December 2024. Patients were randomly assigned to a training set (70%) and an internal validation set (30%). Least absolute shrinkage and selection operator (LASSO) regression was used to screen potential risk factors, followed by multivariate logistic regression to construct the predictive model and generate the nomogram. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA). Results: Seven predictors were ultimately included in the nomogram: age, gender, prior stent implantation, total cholesterol, left ventricular ejection fraction (LVEF), high-density lipoprotein, and albumin. The model exhibited good discrimination, with an AUC of 0.84 (95% CI [0.79-0.90]) in the training set and 0.79 (95% CI [0.68-0.89]) in the validation set. Accuracy was 0.81 in both datasets. Calibration curves and decision curve analysis demonstrated good predictive accuracy and clinical utility of the nomogram. Furthermore, the nomogram scores successfully stratified patients into high-risk (≥191) and low-risk (<191) groups, with significantly different score distributions between the MVD and non-MVD groups (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.